44 participants
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-22
- Start Date:
- 2023-08-07
- Completion:
- 2026-03-31
Conditions
- Non-hodgkin Lymphoma
- Acute Lymphoblastic Leukaemia
- Chronic Lymphocytic Leukemia
Interventions
- BIOLOGICAL
No Results Yet